Ceedar AI is excited to announce a pivotal milestone in our journey—we have successfully raised $200,000 in funding, marking a major step forward as we continue to redefine the way businesses manage their finances. Built on the belief that it's time to retire the old ways, Ceedar offers a revolutionary solution in the financial technology space. Our platform provides done-for-you bookkeeping, up-to-date financials, and maximized tax deductions, all seamlessly integrated into one modern system that adapts to your business needs. With this fresh infusion of capital, we are dedicated to enhancing our product, increasing platform reliability, and rolling out powerful new features designed to empower business owners with precise, real-time financial insights. The funds will also support our efforts in scaling our operations, improving customer support, and expanding our reach to new markets. Currently available in Canada, our goal is to make financial management smoother and more intuitive by bridging traditional bookkeeping with advanced technological integrations. We are enthusiastic about the potential to serve a broader audience and invite businesses from the United States to join our waitlist as we prepare for our upcoming launch stateside. This funding round not only accelerates our product development but also reinforces our commitment to help businesses transition away from outdated practices and toward more efficient, streamlined financial operations. We thank our investors, early adopters, and the entire Ceedar AI community for believing in our vision. Together, we are reshaping the future of financial management.
Ceedar AI Raises $200K to Revolutionize Bookkeeping: Welcome to the Future of Financial Management!
Get the full Ceedar AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today